Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Cost of Revenue (2016 - 2026)

Orthofix Medical has reported Cost of Revenue over the past 17 years, most recently at $57.2 million for Q1 2026.

  • For the quarter ending Q1 2026, Cost of Revenue fell 20.64% year-over-year to $57.2 million, compared with a TTM value of $241.4 million through Mar 2026, down 8.64%, and an annual FY2025 reading of $256.3 million, up 1.06% over the prior year.
  • Cost of Revenue came in at $57.2 million for Q1 2026, down from $63.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $72.0 million in Q1 2025 to a low of -$27.6 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $61.6 million (2024), compared with a mean of $52.0 million.
  • The sharpest move saw Cost of Revenue crashed 183.56% in 2023, then soared 341.92% in 2024.
  • Over 5 years, Cost of Revenue stood at $33.1 million in 2022, then tumbled by 183.56% to -$27.6 million in 2023, then soared by 341.92% to $66.8 million in 2024, then fell by 4.86% to $63.6 million in 2025, then dropped by 10.08% to $57.2 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Cost of Revenue are $57.2 million (Q1 2026), $63.6 million (Q4 2025), and $57.1 million (Q3 2025).